Puma Biotechnology Inc
NASDAQ:PBYI
Gross Margin
Puma Biotechnology Inc
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | US |
Market Cap | 199.6m USD |
Gross Margin |
73%
|
Country | US |
Market Cap | 279.6B USD |
Gross Margin |
66%
|
Country | US |
Market Cap | 164.3B USD |
Gross Margin |
66%
|
Country | US |
Market Cap | 116.4B USD |
Gross Margin |
87%
|
Country | US |
Market Cap | 108B USD |
Gross Margin |
86%
|
Country | AU |
Market Cap | 136.2B AUD |
Gross Margin |
52%
|
Country | US |
Market Cap | 82.5B USD |
Gross Margin |
76%
|
Country | US |
Market Cap | 62.7B USD |
Gross Margin |
22%
|
Country | US |
Market Cap | 43.1B USD |
Gross Margin |
75%
|
Country | US |
Market Cap | 31.8B USD |
Gross Margin |
75%
|
Country | KR |
Market Cap | 38T KRW |
Gross Margin |
47%
|
Profitability Report
View the profitability report to see the full profitability analysis for Puma Biotechnology Inc.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Puma Biotechnology Inc's most recent financial statements, the company has Gross Margin of 73.4%.